CompletedPhase 1NCT03178695
Inovium Ovarian Rejuvenation Trials
Studying Fragile X-associated primary ovarian insufficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ascendance Biomedical
- Principal Investigator
- E Scott Sills, MD PhDCenter for Advanced Genetics (CAG)
- Intervention
- Autologous PRP injection into human ovarian tissue(other)
- Enrollment
- 200 enrolled
- Eligibility
- 35 years · FEMALE
- Timeline
- 2017 – 2018
Study locations (1)
- Center for Advanced Genetics, Carlsbad, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03178695 on ClinicalTrials.gov